Sridama V, Hansasuta P, Pasatrat S, Bunnag S
Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
J Med Assoc Thai. 1990 Mar;73(3):130-5.
Evaluation of diabetic control was performed by using fasting plasma glucose, hemoglobin A1 and fructosamine in 139 patients with diabetes mellitus, and 36 normal controls. A linear correlation of fasting plasma glucose with fructosamine and hemoglobin A1 was found. Using fasting plasma glucose alone was found to be inadequate to define good control. HbA1 and fructosamine had an acceptable sensitivity and specificity in assessment of diabetic control, although fructosamine was slightly less sensitive than HbA1. In patients with thalassemia, hemoglobin A1 levels were elevated in 18 of 19 patients. Fructosamine levels also gave misleading results since 6 to 19 patients had an elevated level and one patient had a decreased level. Patients with hypoproteinemia had a decreased fructosamine and hemoglobin A1 level compared to normal control. HbA1 and fructosamine should be cautiously interpreted in patients with thalassemia and hypoproteinemic states. Using these methods in combination with other measure such as home monitoring of blood glucose would be more precise particularly in diabetic patients with hypoproteinemia, abnormal hemoglobin and other hemolytic disorders.
对139例糖尿病患者和36例正常对照者采用空腹血糖、糖化血红蛋白A1和果糖胺评估糖尿病控制情况。发现空腹血糖与果糖胺和糖化血红蛋白A1呈线性相关。仅使用空腹血糖被发现不足以定义良好的控制情况。糖化血红蛋白A1和果糖胺在评估糖尿病控制方面具有可接受的敏感性和特异性,尽管果糖胺的敏感性略低于糖化血红蛋白A1。在地中海贫血患者中,19例患者中有18例糖化血红蛋白A1水平升高。果糖胺水平也给出了误导性结果,因为6至19例患者水平升高,1例患者水平降低。与正常对照相比,低蛋白血症患者的果糖胺和糖化血红蛋白A1水平降低。在地中海贫血和低蛋白血症状态的患者中,对糖化血红蛋白A1和果糖胺的解读应谨慎。将这些方法与其他措施如家庭血糖监测相结合会更精确,尤其是在患有低蛋白血症、血红蛋白异常和其他溶血性疾病的糖尿病患者中。